MARKET

XXII

XXII

22ND CENTURY
AMEX

Real-time Quotes | Nasdaq Last Sale

0.7558
-0.0199
-2.57%
After Hours: 0.7677 +0.0119 +1.57% 17:47 07/10 EDT
OPEN
0.7750
PREV CLOSE
0.7757
HIGH
0.7849
LOW
0.7525
VOLUME
1.05M
TURNOVER
--
52 WEEK HIGH
2.460
52 WEEK LOW
0.6000
MARKET CAP
104.95M
P/E (TTM)
-3.3847
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average XXII stock price target is 11.50 with a high estimate of 11.50 and a low estimate of 11.50.

EPS

XXII News

More
22nd Century Group to Host Webcast of 2020 Second Quarter Results
GlobeNewswire · 2d ago
Insider Buys 22nd Century Group's Stock
Benzinga · 07/01 15:59
'Surge in use of heated tobacco products expected after proposed ban in Hong Kong fails to get beyond legislative stage' -South China Morning Post Report
https://www.scmp.com/news/hong-kong/health-environment/article/3088105/surge-use-heated-tobacco-products-expected-after?utm_term=Autofeed&utm_medium=Social&utm_content=article&utm_source=Twitter#Echobox=15916
Benzinga · 06/08 15:40
Trade Alert: The Independent Chairman Of 22nd Century Group, Inc. (NYSEMKT:XXII), Nora Sullivan, Has Just Spent US$83k Buying 174% More Shares
Simply Wall St. · 06/08 14:03
22nd Century Group appoints new CEO and CFO
22nd Century Group (NYSEMKT:XXII) has appointed James A. Mish as CEO, effective June 22, 2020, and John Franzino as CFO, effective immediately. Most recent
seekingalpha · 06/03 16:14
22nd Century Group Appoints James A. Mish as Chief Executive Officer and John Franzino as Chief Financial Officer
GlobeNewswire · 06/03 11:45
22nd Century Group Appoints James A. Mish As Chief Executive Officer And John Franzino As Chief Financial Officer
Benzinga · 06/03 10:46
Edited Transcript of XXII earnings conference call or presentation 7-May-20 12:00pm GMT
Thomson Reuters StreetEvents · 05/24 21:52

Industry

Environmental Services & Equipment
+1.84%
Professional & Commercial Services
+0.62%

Hot Stocks

Symbol
Price
%Change

About XXII

22nd Century Group, Inc. is a plant biotechnology company. The Company is focused on technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and levels of cannabinoids in cannabis plants through genetic engineering and plant breeding. It is engaged in various activities, including research and development of less harmful or modified risk tobacco products and tobacco plant varieties; development of X-22, a smoking cessation aid consisting of very low nicotine (VLN) cigarettes; manufacture, marketing and distribution of its RED SUN and MAGIC cigarettes; production of SPECTRUM research cigarettes for the National Institute on Drug Abuse (NIDA); contract manufacturing of third-party branded tobacco products, and research and development of plant varieties of hemp/cannabis, such as plants with low to no amounts of delta-9-tetrahydrocannabinol (THC), plants with high levels of cannabidiol (CBD), and other non-THC cannabinoids.
More

Webull offers kinds of 22nd Century Group Inc stock information, including AMEX:XXII real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XXII stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading XXII stock methods without spending real money on the virtual paper trading platform.